Matrix metalloproteinases in tumour invasion and metastasis
Open Access
- 27 October 1999
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 189 (3) , 300-308
- https://doi.org/10.1002/(sici)1096-9896(199911)189:3<300::aid-path456>3.0.co;2-c
Abstract
The matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes, which are involved in the degradation of many different components of the extracellular matrix. The MMPs have been classified into different groups including collagenases, gelatinases, stromelysins, and others, particularly membrane‐type MMPs, based mainly on the in vitro substrate specificity of individual MMPs. There is increasing evidence to indicate that individual MMPs have important roles in tumour invasion and metastasis. However, the current concept of the role of MMPs in tumour invasion is that they not only have a direct role in tumour invasion by facilitating extracellular matrix degradation, but as a consequence they also have an important role in maintaining the tumour micro‐environment and thus promoting tumour growth. Inhibiting the action of MMPs represents a new therapeutic approach for the treatment of individual types of cancer and several broad‐spectrum, low‐molecular‐weight MMP inhibitors are currently being assessed for clinical use. This review examines the role of MMPs in tumour invasion and metastasis, with an emphasis on studies of clinical relevance. Copyright © 1999 John Wiley & Sons, Ltd.Keywords
This publication has 54 references indexed in Scilit:
- Matrix metalloproteinases and their inhibitors in gastric cancerGut, 1998
- Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3Journal of Biological Chemistry, 1997
- Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4Oncogene, 1997
- Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast CarcinomasJapanese Journal of Cancer Research, 1996
- Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic MiceJNCI Journal of the National Cancer Institute, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Expression of stromelysin-3 and nm23 in breast carcinoma and related tissuesInternational Journal of Cancer, 1994
- Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a reviewBreast Cancer Research and Treatment, 1993
- Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblastsGene, 1992
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990